SCHEDULE: Law Custodial Discloses 15.9% Stake in Dare Bioscience

Law Custodial Inc. has reported a 15.9% beneficial ownership stake in Dare Bioscience, Inc., holding 1,409,167 ordinary shares.

Summary

• Law Custodial Inc., based in Samoa, filed a Schedule 13G, disclosing beneficial ownership of Dare Bioscience, Inc. ordinary shares.
• The reporting person holds 1,409,167 ordinary shares of Dare Bioscience, Inc.
• This ownership represents approximately 15.9% of Dare Bioscience's ordinary shares outstanding.
• The percentage is calculated based on 8,871,155 shares outstanding as of June 30, 2025, as reported by the issuer on August 14, 2025.
• Law Custodial Inc. possesses sole voting and dispositive power over all 1,409,167 shares.
• Of the total, 795,271 ordinary shares are held as a trustee with sole voting and dispositive power.
• The filing certifies that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The disclosure of a significant passive stake by an institutional investor is generally viewed as a neutral to slightly positive signal, indicating confidence without intent to disrupt management. The explicit certification against influencing control reduces potential uncertainty.

Positives

• A significant institutional ownership stake of 15.9% by Law Custodial Inc. may signal confidence in Dare Bioscience, Inc.'s long-term prospects.
• The reporting person explicitly certified that the shares were not acquired to change or influence control, indicating a passive investment stance and reducing potential activist concerns.

Risks

• While the filing certifies no intent to influence control, a large beneficial ownership stake could still represent a concentration risk if the holder were to divest rapidly in the future.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Dare Bioscience, Inc. or Law Custodial Inc. regarding future performance or strategic direction.

Industry Context

This filing indicates a significant passive investment by an institutional entity in Dare Bioscience, Inc., a common occurrence in the public markets where investors acquire stakes for portfolio diversification or long-term value appreciation. It does not provide specific insights into broader industry trends beyond the general activity of institutional investment.

Stakeholder Impact

• Shareholders: Increased institutional ownership may be perceived positively, potentially signaling validation of the company's value proposition. The passive nature of the investment, as certified, suggests stability rather than activist pressure.

Next Steps

• The filing does not outline any specific future actions, events, or milestones for Dare Bioscience, Inc. or Law Custodial Inc. beyond the regulatory disclosure itself.

Key Dates

Recommendation

The Schedule 13G filing by Law Custodial Inc. indicates a significant, passive beneficial ownership stake in Dare Bioscience, Inc. While a large institutional investment can be a positive signal, the filing itself does not provide sufficient new operational or financial data to warrant a 'buy' or 'sell' recommendation. The certification of no intent to influence control suggests a stable, long-term holding rather than an activist position. Therefore, a 'hold' recommendation is appropriate, pending further fundamental analysis of Dare Bioscience's financial performance and strategic developments.

Keywords

Dare Bioscience, Law Custodial Inc., Schedule 13G, Beneficial Ownership, Ordinary Shares, Institutional Investor, SEC Filing, Equity Stake, 23666P2002